Samsung BioLogics shares plunge after regulator says co breached accounting rules
Samsung BioLogics shares plunge after regulator says co breached accounting rules
Shares in Samsung BioLogics Co Ltd fell over 18 percent on Wednesday as South Korea`s watchdog Financial Supervisory Service provisionally decided it had breached accounting rules.
Shares in Samsung C&T Corp , which holds a 43 percent stake in drug contract manufacturer Samsung BioLogics, also fell more than 5 percent.
Samsung BioLogics said in a regulatory filing that it will prove it had engaged in proper accounting practices.
(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.